Terms: = Brain cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300
93 results:
1. Group 3 medulloblastoma transcriptional networks collapse under domain specific ep300/CBP inhibition.
Shendy NAM; Bikowitz M; Sigua LH; Zhang Y; Mercier A; Khashana Y; Nance S; Liu Q; Delahunty IM; Robinson S; Goel V; Rees MG; Ronan MA; Wang T; Kocak M; Roth JA; Wang Y; Freeman BB; Orr BA; Abraham BJ; Roussel MF; Schonbrunn E; Qi J; Durbin AD
Nat Commun; 2024 Apr; 15(1):3483. PubMed ID: 38664416
[TBL] [Abstract] [Full Text] [Related]
2. BCOR::CREBBP fusion in malignant neuroepithelial tumor of CNS expands the spectrum of methylation class CNS tumor with BCOR/BCOR(L1)-fusion.
Ebrahimi A; Waha A; Schittenhelm J; Gohla G; Schuhmann MU; Pietsch T
Acta Neuropathol Commun; 2024 Apr; 12(1):60. PubMed ID: 38637838
[TBL] [Abstract] [Full Text] [Related]
3. HDAC8-mediated inhibition of ep300 drives a transcriptional state that increases melanoma brain metastasis.
Emmons MF; Bennett RL; Riva A; Gupta K; Carvalho LADC; Zhang C; Macaulay R; Dupéré-Richér D; Fang B; Seto E; Koomen JM; Li J; Chen YA; Forsyth PA; Licht JD; Smalley KSM
Nat Commun; 2023 Nov; 14(1):7759. PubMed ID: 38030596
[TBL] [Abstract] [Full Text] [Related]
4. BCOR expression in paediatric pineoblastoma.
Trubicka J; Łastowska M; Karkucińska-Więckowska A; Niemira M; Ejmont M; Sowińska A; Pronicki M; Matyja E; Grajkowska W
Folia Neuropathol; 2023; 61(2):121-128. PubMed ID: 37587886
[TBL] [Abstract] [Full Text] [Related]
5. Benefits of intervention in the Central Auditory Nervous System in individuals with Neurofibromatosis Type 1.
Fontanelli RCFL; Aragão MM; Pinho RS; Gil D
Int J Pediatr Otorhinolaryngol; 2023 Sep; 172():111692. PubMed ID: 37542812
[TBL] [Abstract] [Full Text] [Related]
6. Dimethyl alpha-ketoglutarate inhibits proliferation in diffuse intrinsic pontine glioma by reprogramming epigenetic and transcriptional networks.
Lee K; Yun S; Park J; Lee S; Carcaboso AM; Yi SJ; Kim K
Biochem Biophys Res Commun; 2023 Oct; 677():6-12. PubMed ID: 37523894
[TBL] [Abstract] [Full Text] [Related]
7. Outcome of Second Line Treatment of Recurrent High- Grade Glioma by re-Irradiation or Bevacizumab-based Chemotherapy: A Cross Sectional Study.
Anvari K; Shahabadi M; Welsh JS; Javadinia SA; Zarei E
Asian Pac J Cancer Prev; 2023 May; 24(5):1507-1511. PubMed ID: 37247269
[TBL] [Abstract] [Full Text] [Related]
8. Protocol for a prospective, longitudinal study of cognitive impairment in young patients with cancer: a multidisciplinary neuroscience approach (Mybrain).
Nordhjem BJT; Tjørnlund M; Thomsen BL; Hjerming M; Kjær TW; Pappot H; Hjalgrim LL
BMJ Open; 2023 May; 13(5):e070534. PubMed ID: 37202143
[TBL] [Abstract] [Full Text] [Related]
9. Sites of transcription initiation drive mRNA isoform selection.
Alfonso-Gonzalez C; Legnini I; Holec S; Arrigoni L; Ozbulut HC; Mateos F; Koppstein D; Rybak-Wolf A; Bönisch U; Rajewsky N; Hilgers V
Cell; 2023 May; 186(11):2438-2455.e22. PubMed ID: 37178687
[TBL] [Abstract] [Full Text] [Related]
10. High-grade neuroepithelial tumor with ep300::BCOR fusion and negative BCOR immunohistochemical expression: a case report.
Sugino H; Satomi K; Mori T; Mukai Y; Honda-Kitahara M; Matsushita Y; Ichimura K; Narita Y; Yoshida A
Brain Tumor Pathol; 2023 Apr; 40(2):133-141. PubMed ID: 36811792
[TBL] [Abstract] [Full Text] [Related]
11. CNS tumor with ep300::BCOR fusion: discussing its prevalence in adult population.
Tauziède-Espariat A; Uro-Coste E; Sievers P; Nicaise Y; Mariet C; Siegfried A; Pierron G; Guillemot D; Benzakoun J; Pallud J; Roques M; Bonneville F; Larrieu-Ciron D; Chaynes P; Saffroy R; Hamelin J; Hasty L; Métais A; Chrétien F; Kool M; Gojo J; Varlet P;
Acta Neuropathol Commun; 2023 Feb; 11(1):26. PubMed ID: 36782314
[TBL] [Abstract] [Full Text] [Related]
12. PGAM4 silencing inhibited glycolysis and chemoresistance to temozolomide in glioma cells.
Lu B; Nie XH; Yin R; Ding P; Su ZZ; Qiu S; Qian YF
Cell Biol Int; 2023 Apr; 47(4):776-786. PubMed ID: 36576012
[TBL] [Abstract] [Full Text] [Related]
13. Transcription factor Nrf2 binds to circRNAPIBF1 to regulate SOD2 in lung adenocarcinoma progression.
Zhang Z; Chen Q; Huang C; Rao D; Sang C; Zhu S; Gu L; Xie C; Tang Z; Xu X
Mol Carcinog; 2022 Dec; 61(12):1161-1176. PubMed ID: 36193777
[TBL] [Abstract] [Full Text] [Related]
14. Diffusely infiltrating glioma with CREBBP-BCORL1 fusion showing overexpression of not only BCORL1 but BCOR: A case report.
Yamazaki A; Arai Y; Fukuoka K; Nakano Y; Hama N; Nakata S; Makino K; Kuroda JI; Shinojima N; Mukasa A; Mikami Y; Ichimura K; Shibata T; Yokoo H; Nobusawa S
Brain Tumor Pathol; 2022 Jul; 39(3):171-178. PubMed ID: 35596897
[TBL] [Abstract] [Full Text] [Related]
15. Tracing the origins of glioblastoma by investigating the role of gliogenic and related neurogenic genes/signaling pathways in GBM development: a systematic review.
Shafi O; Siddiqui G
World J Surg Oncol; 2022 May; 20(1):146. PubMed ID: 35538578
[TBL] [Abstract] [Full Text] [Related]
16. The p300 Inhibitor A-485 Exerts Antitumor Activity in Growth Hormone Pituitary Adenoma.
Ji C; Xu W; Ding H; Chen Z; Shi C; Han J; Yu L; Qiao N; Zhang Y; Cao X; Zhou X; Cheng H; Feng H; Luo C; Li Z; Zhou B; Ye Z; Zhao Y
J Clin Endocrinol Metab; 2022 May; 107(6):e2291-e2300. PubMed ID: 35247260
[TBL] [Abstract] [Full Text] [Related]
17. RBBP4-p300 axis modulates expression of genes essential for cell survival and is a potential target for therapy in glioblastoma.
Mladek AC; Yan H; Tian S; Decker PA; Burgenske DM; Bakken K; Hu Z; He L; Connors MA; Carlson BL; Wilson J; Bommi-Reddy A; Conery A; Eckel-Passow JE; Sarkaria JN; Kitange GJ
Neuro Oncol; 2022 Aug; 24(8):1261-1272. PubMed ID: 35231103
[TBL] [Abstract] [Full Text] [Related]
18. Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors.
Sievers P; Henneken SC; Blume C; Sill M; Schrimpf D; Stichel D; Okonechnikov K; Reuss DE; Benzel J; Maaß KK; Kool M; Sturm D; Zheng T; Ghasemi DR; Kohlhof-Meinecke P; Cruz O; Suñol M; Lavarino C; Ruf V; Boldt HB; Pagès M; Pouget C; Schweizer L; Kranendonk MEG; Akhtar N; Bunkowski S; Stadelmann C; Schüller U; Mueller WC; Dohmen H; Acker T; Harter PN; Mawrin C; Beschorner R; Brandner S; Snuderl M; Abdullaev Z; Aldape K; Gilbert MR; Armstrong TS; Ellison DW; Capper D; Ichimura K; Reifenberger G; Grundy RG; Jabado N; Krskova L; Zapotocky M; Vicha A; Varlet P; Wesseling P; Rutkowski S; Korshunov A; Wick W; Pfister SM; Jones DTW; von Deimling A; Pajtler KW; Sahm F
Acta Neuropathol; 2021 Nov; 142(5):827-839. PubMed ID: 34355256
[TBL] [Abstract] [Full Text] [Related]
19. Genome-wide CRISPR screens reveal synthetic lethal interaction between CREBBP and ep300 in diffuse large B-cell lymphoma.
Nie M; Du L; Ren W; Joung J; Ye X; Shi X; Ciftci S; Liu D; Wu K; Zhang F; Pan-Hammarström Q
Cell Death Dis; 2021 Apr; 12(5):419. PubMed ID: 33911074
[TBL] [Abstract] [Full Text] [Related]
20. [Clinical features and prognosis of patients with leptomeningeal metastases].
Zhang ML; Ma WF; Gao XY; Shi YY; Liu HQ; Jiang YS; Qin LZ; Yuan LP; Li W; Zhang JW
Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(16):1154-1159. PubMed ID: 33902246
[No Abstract] [Full Text] [Related]
[Next]
